Skip to main content

CORRECTION article

Front. Pharmacol., 02 May 2022
Sec. Translational Pharmacology
Volume 13 - 2022 | https://doi.org/10.3389/fphar.2022.892656

Corrigendum: Molecular Docking as a Therapeutic Approach for Targeting Cancer Stem Cell Metabolic Processes

This article is a correction to:

  1. Molecular Docking as a Therapeutic Approach for Targeting Cancer Stem Cell Metabolic Processes

    1. Read original article
Babak Arjmand Babak Arjmand1*Shayesteh Kokabi HamidpourShayesteh Kokabi Hamidpour1Sepideh Alavi-MoghadamSepideh Alavi-Moghadam1Hanieh YavariHanieh Yavari1Ainaz ShahbazbadrAinaz Shahbazbadr1Mostafa Rezaei-TaviraniMostafa Rezaei-Tavirani2Kambiz Gilany,Kambiz Gilany3,4Bagher Larijani Bagher Larijani5*
  • 1Cell Therapy and Regenerative Medicine Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
  • 2Proteomics Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  • 3Integrative Oncology Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran
  • 4Reproductive Immunology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran
  • 5Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

Molecular Docking as a Therapeutic Approach for Targeting Cancer Stem Cell Metabolic Processes

by Arjmand, B., Hamidpour, S. K., Alavi-Moghadam, S., Yavari, H., Shahbazbadr, A., Tavirani, M. R., and Larijani, B. (2022). Front. Pharmacol. 13:768556. doi: 10.3389/fphar.2022.768556

In the published article, there was an error in affiliation 3, 4, 5. Instead of “3 Reproductive Immunology Research Center, Avicenna Research Institute (ARI), Tehran, Iran, 4 Department of Biomedical Sciences, Institute of Tropical Medicine Antwerp, Antwerp, Belgium, 5 Breast Cancer Research Center, Motamed Cancer Institute, Tehran, Iran”, it should be “3 Integrative Oncology Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran, 4 Reproductive Immunology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran, 5 Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors, and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: cancer, cancer stem cells, drug designing, metabolic processes, molecular docking

Citation: Arjmand B, Kokabi Hamidpour S, Alavi-Moghadam S, Yavari H, Shahbazbadr A, Rezaei-Tavirani M, Gilany K and Larijani B (2022) Corrigendum: Molecular Docking as a Therapeutic Approach for Targeting Cancer Stem Cell Metabolic Processes. Front. Pharmacol. 13:892656. doi: 10.3389/fphar.2022.892656

Received: 09 March 2022; Accepted: 06 April 2022;
Published: 02 May 2022.

Edited and reviewed by:

Linsheng Liu, The First Affiliated Hospital of Soochow University, China

Copyright © 2022 Arjmand, Kokabi Hamidpour, Alavi-Moghadam, Yavari, Shahbazbadr, Rezaei-Tavirani, Gilany and Larijani. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Babak Arjmand, barjmand@sina.tums.ac.ir; Bagher Larijani, emrc@tums.ac.ir

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.